Health
J&J starts two-dose UK vaccine trial – Yahoo News Australia
US drugmaker Johnson & Johnson has launched a late-stage trial in Britain to test a two-dose regimen of its experimental COVID-19 vaccine
Johnson & Johnson has launched a late-stage trial in Britain to test a two-dose regimen of its experimental COVID-19 vaccine among thousands of volunteers.
In expanding its trials by geography and type, the UK arm of the drugmaker’s study aims to recruit 6000 participants among a total of 30,000 people globally.
Volunteers will be recruited at 17 sites and given a first dose of either a placebo or the experimental shot, currently called Ad26COV2.
That will be followed by a second dose or placebo…
-
Noosa News16 hours agoBike riders to cycle across the traffic lanes of the Story Bridge
-
Business19 hours agoThese are the 10 most shorted ASX shares 9 June 2025
-
Noosa News22 hours agoMen extradited from NSW to face deprivation of liberty and extortion charges
-
General15 hours agoHeroic surfing priest rescues father and son from rip at Cable Beach